CCOP, Central Illinois

Springfield, Illinois 62526

0 studies enrolling now · 29 studies all time

What they study most

Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Breast Cancer, Esophageal Cancer, Fallopian Tube Cancer, Gastric Cancer, Head and Neck Cancer, Invasive Breast Cancer, Leukemia, Lung Cancer, Lymphoma, Melanoma (Skin)

Studies at this site

• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach — Completed
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia — Completed
• Combination Chemotherapy in Treating Women With Breast Cancer — Completed
• Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer — Completed
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Talc in Treating Patients With Malignant Pleural Effusion — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia — Completed
• S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia — Completed
• Brachytherapy in Treating Patients With Prostate Cancer — Completed
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma — Completed
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer — Completed
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer — Completed
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer — Completed
• Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
• Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer — Completed
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early
• S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer — Completed
• S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer — Completed
• S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery — Stopped early
• S9804: Vinorelbine in Treating Patients With Stage IV Melanoma — Completed
• S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer — Completed
• S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer — Completed